Compare BridgeBio Pharma Inc (BBIO) vs Lemonade Inc (LMND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Lemonade Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Lemonade Inc trades at $52.52 (market cap $4.09B). The key difference: BridgeBio Pharma Inc is far larger — about 4× Lemonade Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Lemonade Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | LMND | |
|---|---|---|
Market Cap | $16.36B | $4.09B |
Sector | Health | Financials |
52-Week High | $90.17 | $96.57 |
52-Week Low | $47.29 | $47.38 |
Enterprise Value | $18.14B | $3.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Lemonade Inc
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →
